Evotec SE Logo

Evotec SE

EVT | F

Overview

Corporate Details

ISIN(s):
DE0005664809 (+1 more)
LEI:
529900F9KI6OYITO9B12
Country:
Germany
Address:
Essener Bogen 7, 22419 Hamburg
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Evotec SE is a life science company that provides drug discovery and development solutions to pharmaceutical and biotechnology companies, as well as academic institutions. The company offers a fully integrated research and development value chain, leveraging proprietary technology platforms and deep disease understanding to accelerate the creation of new medicines. Its expertise spans multiple therapeutic modalities, from small molecules to biotherapeutics. Through its Just – Evotec Biologics subsidiary, the company also provides advanced solutions for the design, development, and manufacturing of biologics. Evotec operates through flexible partnership models, aiming to enhance the speed, efficiency, and quality of bringing novel treatments to patients.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Evotec SE. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-27 15:04
Director's Dealing
Evotec SE: Dr. Christian Wojczewski, buy
English 5.9 KB
2025-08-20 11:29
Declaration of Voting Results & Voting Rights Announcements
English 54.3 KB
2025-08-13 07:00
Earnings Release
Evotec SE reports H1 2025 results: Strong progress on strategy execution
English 18.4 KB
2025-08-13 00:00
Interim Report
Half-yearly financial report 2025
English 613.3 KB
2025-08-11 16:40
Declaration of Voting Results & Voting Rights Announcements
English 59.5 KB
2025-08-06 09:52
Report Publication Announcement
Evotec SE to announce first half-year results 2025 on 13 August 2025
English 11.3 KB
2025-07-30 07:16
M&A Activity
Evotec and Sandoz evolve their strategic partnership and agree on potential sal…
English 14.5 KB
2025-07-23 15:34
Declaration of Voting Results & Voting Rights Announcements
English 56.9 KB
2025-07-21 11:40
Earnings Release
Evotec adjusts revenue guidance and confirms profit guidance anticipating a mor…
English 13.3 KB
2025-07-15 11:35
Declaration of Voting Results & Voting Rights Announcements
English 56.9 KB
2025-06-30 11:00
Declaration of Voting Results & Voting Rights Announcements
Release according to Article 41 of the WpHG [the German Securities Trading Act]…
English 4.4 KB
2025-06-25 07:30
Regulatory News Service
Evotec joins NURTuRE-AKI consortium to gain multi-omics-based molecular underst…
English 16.4 KB
2025-06-19 17:10
Declaration of Voting Results & Voting Rights Announcements
English 17.5 KB
2025-06-13 00:00
Governance Information
Declaration of Corporate Management 2024
English 742.8 KB
2025-06-03 17:00
Post-Annual General Meeting Information
Evotec SE: Results of the Annual General Meeting 2025
English 11.3 KB

Automate Your Workflow. Get a real-time feed of all Evotec SE filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Evotec SE via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-02-06 Dohrmann, Dr. Cord Board Other None 91,363.32 EUR
2024-10-01 Rouxel, Laetitia Board Other None 58,396.84 EUR
2024-09-13 Wojczewski, Dr. Christian Board Buy None 61,087.50 EUR
2024-09-05 Dalbiez, Aurélie Board Buy None 21,202.55 EUR
2024-09-02 Wojczewski, Dr. Christian Board Buy None 64,466.00 EUR
2024-08-29 Löw-Friedrich, Prof. Dr. Iris Supervisory board Buy None 100,050.00 EUR
2024-08-23 Wojczewski, Dr. Christian Board Buy None 113,291.94 EUR
2024-08-22 Johnstone, Dr. Craig Board Buy None 16,553.03 EUR
2024-08-19 Wojczewski, Dr. Christian Board Buy None 59,766.00 EUR
2024-05-03 Dohrmann, Dr. Cord Board Other None 76,220.10 EUR

Peer Companies

Company Country Ticker View
1NKEMIA Logo
Offers contract R&D, develops tech platforms, and invests in life sciences ventures.
Spain IKM
2cureX AB Logo
Tests cancer drugs on patient-derived micro-tumors for personalized oncology treatments.
Sweden 2CUREX
4SC AG Logo
Developing epigenetic small-molecule drugs for cancers with high unmet medical needs.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using an OMV platform for major infectious diseases.
Sweden ABERA
ABIVAX Logo
Developing oral drugs for chronic inflammatory diseases like ulcerative colitis and Crohn's disease.
France ABVX
Abliva Logo
A clinical-stage biotech developing medicines for rare primary mitochondrial diseases.
Sweden ABLI
Achiko AG Logo
A liquidated health tech firm that developed aptamer diagnostics and a COVID-19 passport app.
Switzerland ACHI
Acticor Biotech Logo
Biopharma developing first-in-class drugs for acute stroke and other thrombotic diseases.
France ALACT
Active Biotech Logo
Develops immunotherapies for cancer and inflammatory diseases with significant unmet needs.
Sweden ACTI
Addex Therapeutics Ltd Logo
Develops oral small molecule drugs, allosteric modulators, for neurological disorders.
Switzerland ADXN